NovaBay Pharmaceuticals, Inc. Capital Stock Change

Capital Stock Change of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Capital Stock Change growth rates and interactive chart.


Highlights and Quick Summary

  • Capital Stock Change for the quarter ending September 30, 2022 was $1.7 Million (a -88.41% decrease compared to previous quarter)
  • Year-over-year quarterly Capital Stock Change decreased by -4.06%
  • Annual Capital Stock Change for 2021 was $16.7 Million (a 35.37% increase from previous year)
  • Annual Capital Stock Change for 2020 was $12.3 Million (a 28.98% increase from previous year)
  • Annual Capital Stock Change for 2019 was $9.56 Million (a 70.73% increase from previous year)
  • Twelve month Capital Stock Change ending September 30, 2022 was $3.48 Million (a 95.34% increase compared to previous quarter)
  • Twelve month trailing Capital Stock Change decreased by -74.97% year-over-year
Trailing Capital Stock Change for the last four month:
30 Sep '22 31 Dec '21 30 Sep '21 30 Jun '21
$3.48 Million $1.78 Million $8.43 Million $13.9 Million
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Capital Stock Change of NovaBay Pharmaceuticals, Inc.

Most recent Capital Stock Changeof NBY including historical data for past 10 years.

Interactive Chart of Capital Stock Change of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Capital Stock Change for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $1.7
2021 $14.69 $0.22 $1.78 $16.68
2020 $0.01 $6.43 $5.69 $0.2 $12.33
2019 $-0.0 $6.85 $2.7 $0.0 $9.56
2018 $0.0 $0.0 $-0.01 $5.6 $5.6
2017 $0.07 $0.15 $0.04 $-0.05 $0.2
2016 $0.86 $10.34 $7.25 $2.63 $21.08
2015 $1.91 $0.34 $7.04 $4.65 $13.95
2014 $0.42 $0.36 $0.05 $6.56 $7.39
2013 $7.02 $1.83 $0.45 $0.03 $9.33
2012 $8.19 $1.31 $0.01 $0.04 $9.54
2011 $0.05 $4.74

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology